Concepedia

Publication | Closed Access

Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study

20

Citations

0

References

2019

Year

No additional data available for this publication yet. Check back later!